Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Richmat is a Chinese manufacturer of intelligent control and linear drive systems used across smart home, healthcare and rehabilitation, office ergonomics, and industrial applications. In healthcare, the company supplies drive and control systems for products such as medical beds, nursing beds, turning beds, wheelchairs, patient transfer devices, and related home-care equipment. Richmat appears to be primarily a hardware and components business rather than a therapeutics developer, with revenue derived from commercialized actuator, controller, handset, lifting column, and control-box products. The company is publicly listed in China and has built a global sales footprint spanning North America, Europe, the Middle East, East Asia, Southeast Asia, and South America. For a biotech analyst, this should be viewed as a medtech/healthcare-enabling equipment and components supplier, not a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Richmat.